Transgenomic PRPO 深 沪
等待开盘 08-26 09:30:00 美东时间
14.19
-0.070
-0.49%
华盛通- 最 高14.49
- 今 开14.04
- 成交量 5282股
- 最 低 14.04
- 昨 收 14.26
- 总市值 2145.53万
- 52周最高 16.89
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 3.90
- 委 比 -71.43%
- 总股本 151.20万
- 历史最高 8448.00
- 量 比 0.70
- 振 幅 3.16%
- 历史最低 3.90
- 每 手 1
- 风险率 3.04%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Precipio Unveils Advancements in AML Diagnostic Technology
The latest announcement is out from Precipio ( ($PRPO) ). On August 18, 2025, P...
08-19 05:32
Precipio Q2 EPS $0.05 Up From $(0.83) YoY, Sales $5.654M Up From $4.441M YoY
Precipio (NASDAQ:PRPO) reported quarterly earnings of $0.05 per share. This is a 106.02 percent increase over losses of $(0.83) per share from the same period last year. The company reported $5.654 million in sales this
08-14 05:05
Precipio Announces its Q2-2025 Financial Results
<p>Precipio Inc., a specialty cancer diagnostics company, reported Q2-2025 financial results with $5.7M in revenue, a 27% YoY and 15% QoQ increase. Adjusted EBITDA improved to $(78K) from $(609K) YoY. Cash flow used decreased 71% YoY. Both product and pathology services divisions showed strong growth, with gross margins improving to 43% overall. The company expects to end the year debt-free and cash flow positive. A conference call is scheduled f...
08-13 21:00
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Sonnet BioTherapeutics (NASDAQ:SONN) shares rose 239.4% to $17.55 dur...
07-14 20:08
Precipio Revises Warrant Agreement With Largest Holder; 100K To Be Exercised For Cash, 200K Through Cashless Conversion
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) has entered into an agreement with its largest warrant holder, amending the existing structure from cash exercise of warrants, to a revised
07-12 04:33
Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless
Precipio, Inc. (NASDAQ: PRPO) has amended its warrant agreement with its largest warrant holder, modifying the cash exercise structure. Under the new terms, 100,000 warrants (about one-third) will be exercised with cash, yielding approximately $1.2 million, while the remaining 200,000 warrants will be exercised cashlessly. This reduces the total shares added to ~130,000-150,000 from ~300,000. Management will discuss the transaction further during...
07-11 20:30
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
Precipio, Inc., a specialty cancer diagnostics company, is urging shareholders to vote their shares by June 16, 2025, at 11 p.m. Eastern Time to ensure a quorum for the upcoming shareholder meeting on June 17, 2025. Currently, 42% of shares have been voted, and at least 50% are needed to hold the meeting. Failing to meet the quorum could result in rescheduling costs as high as $100,000. Precipio develops innovative cancer diagnostic solutions to ...
06-16 16:00
Precipio Schedules Q1-2025 Shareholder Update Call
An update from Precipio ( ($PRPO) ) is now available. On May 1, 2025, Precipio,...
05-07 04:59
Precipio’s Earnings Call: Growth Amid Challenges
Precipio (($PRPO)) has held its Q4 earnings call. Read on for the main highligh...
04-02 08:16
Precipio Reports Positive Q4 Financial Results
Precipio ( ($PRPO) ) has released its Q4 earnings. Here is a breakdown of the i...
04-01 12:03
